FDA Panel Recommends Approval for Multi-Cancer Blood Test
1 report, 1 independent
Updated Sep 23
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
An advisory panel for the Food and Drug Administration recommended the approval of a multi-cancer blood test. This test can detect more than 50 types of cancer in adults aged 50 or older by analyzing RNA signals in the blood.
Why it matters
The blood test offers a less invasive alternative for cancer detection. Experts state that the increased sensitivity of the technology has allowed for the detection of these signals, which could change how cancer care pathways are managed.
The Food and Drug Administration has previously cleared a blood test for diagnosis, which offers a less invasive alternative.
Who's involved
- Food and Drug AdministrationThe government agency whose advisory panel recommended the blood test approval